PolyPid
PYPD
17 hedge funds and large institutions have $566K invested in PolyPid in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 14 closing their positions.
31% more call options, than puts
Call options by funds: $209K | Put options by funds: $160K
0.1% less ownership
Funds ownership: 0.18% → 0.08% (-0.1%)
37% less funds holding
Funds holding: 27 → 17 (-10)
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
71% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 14
89% less capital invested
Capital invested by funds: $4.95M → $566K (-$4.38M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$264K |
| 2 |
Simplex Trading
Chicago,
Illinois
|
+$226K |
| 3 |
XS
XR Securities
Chicago,
Illinois
|
+$68.9K |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$61.8K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$5.81K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1.3M |
| 2 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$666K |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
-$534K |
| 4 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
-$145K |
| 5 |
Morgan Stanley
New York
|
-$126K |
PYPD Hedge Fund Activity: Q3 2022 in Review
17 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in PolyPid (PYPD) for Q3 2022, worth a combined $566K — down 89% from $4.95M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of PYPD and 4 opened new positions — a net loss of 10 holders — while 5 trimmed existing stakes and 2 added.
The largest buyer was Millennium Management, opening a new position worth an estimated $264K. The largest seller was UBS Group, exiting entirely with an estimated $1.3M sold.
- 17 institutional investors held PolyPid (PYPD) as of Q3 2022, down from 27 in Q2 2022.
- Funds reported $566K of PolyPid stock for Q3 2022, down 89% quarter-over-quarter.
- 4 funds opened new PolyPid positions in Q3 2022 and 14 closed out, a net change of -10 holders.
- The largest PolyPid buyer in Q3 2022 was Millennium Management, an estimated $264K added.
- The largest PolyPid seller in Q3 2022 was UBS Group, an estimated $1.3M sold.
Based on aggregated 13F filings for Q3 2022.